↓ Skip to main content

Dove Medical Press

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy…

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2013
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley